Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
4
×
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
detroit blog main
detroit top stories
indiana blog main
indiana top stories
4
×
life sciences
merck
4
×
national
national blog main
national top stories
new york blog main
new york top stories
pfizer
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
4
×
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
bristol-myers squibb
roche
seattle genetics
vertex pharmaceuticals
alzheimer's disease
astrazeneca
biontech
biotech ipos
bridgebio
What
bio
roundup
buy
drug
acquisitions
advantages
alliance
annual
ash
bar
barcelona
biggest
brings
bristol
build
calls
cancer
ceo
changing
clinical
color
company’s
conference
crispr
daniel
days
debut
december's
dyne’s
esmo
european
expect
gamble
gilead
growing
hours
kras
kudos
leaves
major
Language
unset
4
×
Current search:
amgen
×
unset
×
" seattle top stories "
×
" indiana top stories "
×
merck
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
ESMO 2019: PARP and Prostate, SeaGen’s Win, KRAS Update & More
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone